Neumora Expands Precision Neuroscience Pipeline with Novel M4 Receptor Modulator Program Through Exclusive License Agreement with Vanderbilt University
Pioneering a New Era of Precision Medicines for Brain Diseases
We are facing a global brain disease crisis, but we are lacking targeted, effective medicines. Patients deserve better.
Recent scientific and technological advancements have revolutionized precision medicines in oncology, and it’s time to develop precision medicines for brain diseases to change the status quo.
Neuroscience R&D. Redefined.